Home/Filings/4/0001213900-25-069530
4//SEC Filing

HILZ MARK T 4

Accession 0001213900-25-069530

CIK 0001468492other

Filed

Jul 29, 8:00 PM ET

Accepted

Jul 30, 9:00 PM ET

Size

6.4 KB

Accession

0001213900-25-069530

Insider Transaction Report

Form 4
Period: 2025-07-29
HILZ MARK T
DirectorSee Remarks
Transactions
  • Sale

    Common Stock, $0.001 par value

    2025-07-29$3.54/sh4,416$15,6214,752 total
Holdings
  • Common Stock, $0.001 par value

    (indirect: See footnote)
    41
Footnotes (3)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2025.
  • [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.52 to $3.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
  • [F3]Represents shares held by the Reporting Person's daughter.

Documents

1 file

Issuer

HeartSciences Inc.

CIK 0001468492

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001016157

Filing Metadata

Form type
4
Filed
Jul 29, 8:00 PM ET
Accepted
Jul 30, 9:00 PM ET
Size
6.4 KB